2020 American College of Rheumatology Guideline for the Management of Gout  FACP  American College of Rheumatology      F80A3E8AB0860BDC6587873AB54E2F45 10.1002/acr.24180 received research support from Hikma Pharmaceuticals and Horizon Pharma. Dr. Singh has received consulting fees, speaking fees, and/or honoraria from Crealta/ Horizon, Medisys, Fidia, UBM, Trio Health, Medscape, WebMD, Clinical Care Options, Clearview Healthcare Partners, Putnam Associates, Spherix, and Practice Point Communications Submitted for publication December 10, 2019; accepted in revised form February 28, 2020.  INTRODUCTION Gout is the most common form of inflammatory arthritis, affecting ~9.2 million adults (3.9%) in the US METHODS This guideline follows the ACR guideline development process ( https://www.rheum atolo gy.org/Pract ice-Quali ty/Clini cal-Suppo rt/Clini cal-Pract ice-Guide lines https://www.rheum atolo gy. org/Pract ice-Quali ty/Clini cal-Suppo rt/Clini cal-Pract ice-Guide lines/ Gout